PQ 416
416. Deputy Pat Buckley asked the Minister for Health the rationale for the exclusion of the drug Roflumilast from being covered by medical cards in view of its prohibitive cost for persons and its effectiveness in treating the severity of COPD. [5661/17]
Introduced
7 February 2017
Last action
7 February 2017 · Medical Card Drugs Availability
Status
written
Sponsors
Pat Buckley
Subjects
Discovery layer
Source updated
7 February 2017
Summary
416. Deputy Pat Buckley asked the Minister for Health the rationale for the exclusion of the drug Roflumilast from being covered by medical cards in view of its prohibitive cost for persons and its effectiveness in treating the severity of COPD. [5661/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 February 2017
Medical Card Drugs Availability
416. Deputy Pat Buckley asked the Minister for Health the rationale for the exclusion of the drug Roflumilast from being covered by medical cards in view of its prohibitive cost for persons and its effectiveness in treating the severity of COPD. [5661/17]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medical Card Drugs Availability
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Medical Card Drugs Availability
xml · EN · 7 February 2017
Sponsors
- Pat Buckley · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-02-07/416/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-02-07/pq_416
- ireland · q-2017-02-07-pq_416 · source updated 7 February 2017